Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
British Journal of Haematology
|
November 3, 2021
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases
Ayalew Tefferi, Jaya Kittur, Faiqa Farrukh, et al.
Blood Cancer Journal
|
January 18, 2024
One thousand patients with essential thrombocythemia: the Mayo Clinic experience
Naseema Gangat, Omer Karrar, Aref Al-Kali, et al.
British Journal of Haematology
|
December 22, 2017
Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis
Ayalew Tefferi, Sahrish Shah, Mythri Mudireddy, et al.
Leukemia & Lymphoma
|
September 17, 2004
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin
Michelle A Elliott, Robert C Wolf, Christopher C Hook, et al.
Annals of Hematology
|
October 19, 2018
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
Omar A Alkharabsheh, Salwa S Saadeh, Darci L Zblewski, et al.
Leukemia & Lymphoma
|
October 1, 2016
Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes
Prashant Sharma, Shivani S Shinde, Moussab Damlaj, et al.
American Journal of Hematology
|
September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide
Ayalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.
Blood Advances
|
March 10, 2022
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events
Naseema Gangat, Natasha Szuber, Yamna Jadoon, et al.
Mayo Clinic Proceedings
|
August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali, Darci Zblewski, James M Foran, et al.
Blood Cancer Journal
|
March 12, 2021
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
Evandro D Bezerra, Terra L Lasho, Christy M Finke, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
British Journal of Haematology
|
November 3, 2021
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases
Ayalew Tefferi, Jaya Kittur, Faiqa Farrukh, et al.
Blood Cancer Journal
|
January 18, 2024
One thousand patients with essential thrombocythemia: the Mayo Clinic experience
Naseema Gangat, Omer Karrar, Aref Al-Kali, et al.
British Journal of Haematology
|
December 22, 2017
Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis
Ayalew Tefferi, Sahrish Shah, Mythri Mudireddy, et al.
Leukemia & Lymphoma
|
September 17, 2004
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin
Michelle A Elliott, Robert C Wolf, Christopher C Hook, et al.
Annals of Hematology
|
October 19, 2018
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
Omar A Alkharabsheh, Salwa S Saadeh, Darci L Zblewski, et al.
Leukemia & Lymphoma
|
October 1, 2016
Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes
Prashant Sharma, Shivani S Shinde, Moussab Damlaj, et al.
American Journal of Hematology
|
September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide
Ayalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.
Blood Advances
|
March 10, 2022
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events
Naseema Gangat, Natasha Szuber, Yamna Jadoon, et al.
Mayo Clinic Proceedings
|
August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali, Darci Zblewski, James M Foran, et al.
Blood Cancer Journal
|
March 12, 2021
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
Evandro D Bezerra, Terra L Lasho, Christy M Finke, et al.
Page
of 9